BackgroundThere is no convincing evidence for the benefit of using anti-D immune globulin (RhIG) in the first trimester [1]. The World Health Organization (WHO) recommends that the determination of Rh status and the offer of RhIG prophylaxis are not considered prerequisites for early first trimester (≤ 63 days) medical abortion [2]. According to the North America Abortion Federation (NAF), it is reasonable to forgo Rh testing and RhIG for women having any type of abortion before 8 weeks from the last menstrual period [3].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.